Skip to content

Clinical trials

Autoimmune Diseases trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Country / region: Serbia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20131
20151
20161
20221
20231
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH3
Viatris Innovation GmbH2
Baxalta now part of Shire1
Eli Lilly and Company1
GlaxoSmithKline1
Human Genome Sciences Inc., a GSK Company1
Kedrion S.p.A.1
Kyowa Kirin, Inc.1
Mabion SA1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases14
Immune System Diseases6
Lupus Erythematosus, Systemic5
Connective Tissue Diseases3
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating3
Abdominal Pain1
Arthritis, Rheumatoid1
Autoimmune Diseases of the Nervous System1
Barth Syndrome1
Blood Coagulation Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.